Neuraminidase inhibitor susceptibility testing in human influenza viruses: A laboratory urveillance perspective

Viruses

Volumn 2, Issue 10, 2010, Pages 2269-2289

  Okomo Adhiambo, Margaret ^a   Sleeman, Katrina ^a   Ballenger, Kristina ^a   Nguyen, Ha T ^a,b   Mishin, Vasiliy P ^a   Sheu, Tiffany G ^a,c   Smagala, James ^a,d   Li, Yan ^e   Klimov, Alexander I ^a   Gubareva, Larisa V ^a  

^a NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^b ATLANTA RESEARCH AND EDUCATION FOUNDATION   (United States)

^c BATTELLE MEMORIAL INSTITUTE   (United States)

^d OAK RIDGE INSTITUTE FOR SCIENCE AND EDUCATION   (United States)

^e PUBLIC HEALTH AGENCY OF CANADA   (Canada)

Author keywords

Oseltamivir; Pandemic H1N1; Peramivir; Seasonal influenza a and b; Zanamivir

Indexed keywords

ASPARTIC ACID; GLUTAMIC ACID; HISTIDINE; OSELTAMIVIR; PERAMIVIR; TYROSINE; VALINE; VIRUS SIALIDASE; ZANAMIVIR;

ANIMAL CELL; ANTIVIRAL RESISTANCE; ANTIVIRAL SUSCEPTIBILITY; ARTICLE; CONTROLLED STUDY; IC 50; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; INFLUENZA VIRUS B; NONHUMAN; VIRUS ISOLATION; VIRUS MUTATION;

CERCOPITHECINE HERPESVIRUS 1; HUMAN INFLUENZA VIRUS; ORTHOMYXOVIRIDAE;

EID: 79952163859     PISSN: None     EISSN: 19994915     Source Type: Journal    
DOI: 10.3390/v2102269     Document Type: Article

References (42)

1. Moscona, A. Medical management of influenza infection. Annu. Rev. Med. 2008, 59, 397-413.
2. Bright, R.A.; Medina, M.J.; Xu, X.; Perez-Oronoz, G.; Wallis, T.R.; Davis, X.M.; Povinelli, L.; Cox, N.J.; Klimov, A.I. Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern. Lancet. 2005, 366, 1175-1181.
3. Deyde, V.M.; Xu X.,; Bright, R.A.; Shaw, M.; Smith, C.B.; Zhang, Y.; Shu, Y.; Gubareva, L.V.; Cox, N.J.; Klimov, A.I. Surveillance of resistance to adamantanes among influenza A(H3N2) and A(H1N1) viruses isolated worldwide. J. Infect. Dis. 2007, 196, 249-257.
4. CDC Website. http://www.cdc.gov/h1n1flu/eua/peramivir.htm (accessed on 28 May 2010).
5. Shionogi and Company Website. http://www.shionogi.co.jp/ir_en/news/detail/e_100126.pdf (accessed on 28 May 2010).
6. Colman, P.M.; Hoyne, P.A.; Lawrence, M.C. Sequence and structure alignment of paramyxovirus hemagglutinin-neuraminidase with influenza virus neuraminidase. J. Virol. 1993, 67, 2972-2980.
7. Ferraris, O.; Lina, B. Mutations of neuraminidase implicated in neuraminidase inhibitors resistance. J. Clin. Virol. 2008, 41, 13-19.
8. Monto, A.S.; McKimm-Breschkin, J.L.; Macken, C.; Hampson, A.W.; Hay, A.; Klimov, A.; Tashiro, M.; Webster, R.G.; Aymard, M.; Hayden, F.G.; Zambon, M. Detection of influenza viruses resistant to neuraminidase inhibitors in global surveillance during the first 3 years of their use. Antimicrob. Agents Chemother. 2006, 50, 2395-2402.
9. Mungall, B.A.; Xu, X.; Klimov, A. Surveillance of influenza isolates for susceptibility to neuraminidase inhibitors during the 2000-2002 influenza seasons. Virus Res. 2004, 103, 195-197.
10. Sheu, T.G.; Deyde, V.M.; Okomo-Adhiambo, M.; Garten, R.J.; Xu, X.; Bright, R.A.; Butler, E.N.; Wallis, T.R.; Klimov, A.I.; Gubareva, L.V. Surveillance for neuraminidase inhibitor resistance among human influenza A and B viruses circulating worldwide from 2004 to 2008. Antimicrob. Agents Chemother. 2008, 52, 3284-3292.
11. Hauge, S.H.; Dudman, S.; Borgen, K.; Lackenby, A.; Hungnes, O. Oseltamivir-resistant influenza viruses A (H1N1), Norway, 2007-08. Emerg. Infect. Dis. 2009, 15, 155-162.
12. CDC. Influenza activity - United States and worldwide, 2007-08 season. Morb. Mortal. Wkly. Rep. 2008, 57, 692-697.
13. Lackenby, A.; Hungnes, O.; Dudman, S.G.; Meijer, A.; Paget, W.J.; Hay, A.J.; Zambon, M.C. Emergence of resistance to oseltamivir among influenza A(H1N1) viruses in Europe. Euro. Surveill. 2008, 13, 8026.
14. Meijer, A.; Lackenby, A.; Hungnes, O.; Lina, B.; van der Werf, S.; Schweiger, B.; Opp, M.; Paget, J.; van de Kassteele, J.; Hay, A.; Zambon, M. Oseltamivir-resistant influenza virus A (H1N1), Europe, 2007-08 Season. Emerg. Infect. Dis. 2009, 15, 552-560.
15. Besselaar, T.G.; Naidoo, D.; Buys, A.; Gregory, V.; McAnerney, J.; Manamela, J.M.; Blumberg, L.; Schoub, B.D. Widespread oseltamivir resistance in influenza A viruses (H1N1), South Africa. Emerg. Infect. Dis. 2008, 14, 1809-1810.
16. CDC. Update: influenza activity - United States, September 28, 2008-January 31, 2009. Morb. Mortal. Wkly. Rep. 2009, 58, 115-119.
17. CDC. Update: influenza activity - United States, September 28, 2008-April 4, 2009, and composition of the 2009-10 influenza vaccine. Morb. Mortal. Wkly. Rep. 2009, 58, 369-374.
18. Baranovich, T.; Saito, R.; Suzuki, Y.; Zaraket, H.; Dapat, C.; Caperig-Dapat, I.; Oguma, T.; Shabana, I.I.; Saito, T.; Suzuki, H. Emergence of H274Y oseltamivir-resistant A(H1N1) influenza viruses in Japan during the 2008-2009 season. J. Clin. Virol. 2010, 47, 23-28.
19. Mungall, B.A.; Xu, X.; Klimov, A. Assaying susceptibility of avian and other influenza A viruses to zanamivir: comparison of fluorescent and chemiluminescent neuraminidase assays. Avian Dis. 2003, 47, 1141-1144.
20. Wetherall, N.T.; Trivedi, T.; Zeller, J.; Hodges-Savola, C.; McKimm-Breschkin, J.L.; Zambon, M.; Hayden, F.G. Evaluation of neuraminidase enzyme assays using different substrates to measure susceptibility of influenza virus clinical isolates to neuraminidase inhibitors: report of the neuraminidase inhibitor susceptibility network. J. Clin. Microbiol. 2003, 41, 742-750.
21. McKimm-Breschkin, J.; Trivedi, T.; Hampson, A.; Hay, A.; Klimov, A.; Tashiro, M.; Hayden, F.; Zambon, M. Neuraminidase sequence analysis and susceptibilities of influenza virus clinical isolates to zanamivir and oseltamivir. Antimicrob. Agents Chemother. 2003, 47, 2264-2272.
22. Mishin, V.P.; Hayden, F.G.; Gubareva, L.V. Susceptibilities of antiviral-resistant influenza viruses to novel neuraminidase inhibitors. Antimicrob. Agents Chemother. 2005, 49, 4515-4520.
23. Buxton, R.C.; Edwards, B.; Juo, R.R.; Voyta, J.C.; Tisdale, M.; Bethell, R.C. Development of a sensitive chemiluminescent neuraminidase assay for the determination of influenza virus susceptibility to zanamivir. Anal. Biochem. 2000, 280, 291-300.
24. Potier, M.; Mameli, L.; Belisle, M.; Dallaire, L.; Melancon, S.B. Fluorometric assay of neuraminidase with a sodium (4-methylumbelliferyl-alpha-D-N-acetylneuraminate) substrate. Anal. Biochem. 1979, 94, 287-296.
25. Hurt, A.C.; Holien, J.K.; Parker, M.; Kelso, A.; Barr, I.G. Zanamivir-Resistant Influenza Viruses with a Novel Neuraminidase Mutation. J. Virol. 2009, 83, 10366-73.
26. Okomo-Adhiambo, M.; Nguyen, H.T.; Sleeman, K.; Sheu, T.G.; Deyde, V.M.; Garten, R.J.; Xu, X.; Shaw, M.W.; Klimov, A.I.; Gubareva, L.V. Host cell selection of influenza neuraminidase variants: implications for drug resistance monitoring in A(H1N1) viruses. Antiviral Res. 2010 85, 381-388.
27. NISN Website. http://www.nisn.org/v_analysis_guidance_ic50.php (accessed on 28 May 2010).
28. Tisdale, M. Monitoring of viral susceptibility: new challenges with the development of influenza NA inhibitors. Rev. Med. Virol. 2000, 10, 45-55.
29. Deyde, V.M.; Okomo-Adhiambo, M.; Sheu, T.G.; Wallis, T.R.; Fry, A.; Dharan, N.; Klimov, A.I.; Gubareva, L.V. Pyrosequencing as a tool to detect molecular markers of resistance to neuraminidase inhibitors in seasonal influenza A viruses. Antiviral Res. 2009, 81, 16-24.
30. Deyde, V.M.; Sheu, T.G.; Trujillo, A.A.; Okomo-Adhiambo, M.; Garten, R.; Klimov, A.I.; Gubareva, L.V. Detection of molecular markers of drug resistance in 2009 pandemic influenza A (H1N1) viruses by pyrosequencing. Antimicrob. Agents Chemother. 2010, 54, 1102-1110.
31. Chidlow, G.R.; Harnett, G.B.; Williams, S.H.; Tempone, S.S.; Speers, D.J.; Hurt, A.C.; Deng, Y. M., Smith, D.W. The detection of oseltamivir-resistant pandemic influenza A/H1N1 2009 viruses using a real-time RT-PCR assay. J. Virol. Methods. 2010, 169, 47-51.
32. van der Vries, E.; Jonges, M.; Herfst, S.; Maaskant, J.; van der Linden, A.; Guldemeester, J.; Aron, G. I.; Bestebroer, T.M.; Koopmans, M.; Meijer, A.; Fouchier, R.A.; Osterhaus, A.D.; Boucher, C.A.; Schutten, M. Evaluation of a rapid molecular algorithm for detection of pandemic influenza A (H1N1) 2009 virus and screening for a key oseltamivir resistance (H275Y) substitution in neuraminidase. J. Clin. Virol. 2010, 47, 34-37.
33. CDC Update: swine influenza A (H1N1) infections--California and Texas, April 2009. Morb. Mortal. Wkly. Rep. 2009, 58, 435-437.
34. Tashiro, M.; McKimm-Breschkin, J.L.; Saito, T.; Klimov, A.; Macken, C.; Zambon, M.; Hayden, F.G. Surveillance for neuraminidase-inhibitor-resistant influenza viruses in Japan, 1996-2007. Antivir. Ther. 2009, 14, 751-761.
35. Hurt, A.C.; Barr, I.G.; Hartel, G.; Hampson, A.W. Susceptibility of human influenza viruses from Australasia and South East Asia to the neuraminidase inhibitors zanamivir and oseltamivir. Antiviral Res. 2004, 62, 37-45.
36. Jonges, M.; van der Lubben I.M.; Dijkstra, F.; Verhoef, L.; Koopmans, M.; Meijer, A. Dynamics of antiviral-resistant influenza viruses in the Netherlands, 2005-2008. Antiviral Res. 2009, 83, 290-297.
37. Lin, Y.P.; Gregory, V.; Collins, P.; Kloess, J.; Wharton, S.; Cattle, N.; Lackenby, A.; Daniels, R.; Hay, A. Neuraminidase Receptor Binding Variants of Human Influenza A(H3N2) Viruses due to Substitution of Aspartic acid 151 in the Catalytic Site - Role in Virus Attachment? J. Virol. 2010, 84, 6769-81.
38. Hurt, A.C.; Iannello, P.; Jachno, K.; Komadina, N.; Hampson, A.W.; Barr, I.G.; McKimm-Breschkin, J.L. Neuraminidase inhibitor-resistant and -sensitive influenza B viruses isolated from an untreated human patient. Antimicrob. Agents Chemother. 2006, 50, 1872-1874.
39. Nguyen, H.T.; Sheu, T.G.; Mishin, V.P.; Klimov, A.I.; Gubareva, L.V. Assessment of Pandemic and Seasonal Influenza A (H1N1) Virus Susceptibility to Neuraminidase Inhibitors in Three Enzyme Activity Inhibition Assays. Antimicrob. Agents Chemother. 2010, 54, 3671-3677.
40. Sugaya, N.; Mitamura, K.; Yamazaki, M.; Tamura, D.; Ichikawa, M.; Kimura, K.; Kawakami, C.; Kiso, M.; Ito, M.; Hatakeyama, S.; Kawaoka, Y. Lower clinical effectiveness of oseltamivir against influenza B contrasted with influenza A infection in children. Clin. Infect. Dis. 2007, 44, 197-202.
41. Sato, M.; Saito, R.; Sato, I.; Tanabe, N.; Shobugawa, Y.; Sasaki, A.; Li, D.; Suzuki, Y.; Sato, M.; Sakai, T.; Oguma, T.; Tsukada, H.; Gejyo, F.; Suzuki, H. Effectiveness of oseltamivir treatment among children with influenza A or B virus infections during four successive winters in Niigata City, Japan. Tohoku J. Exp. Med. 2008, 214, 113-120.
42. Ferraris, O.; Kessler, N.; Lina, B. Sensitivity of influenza viruses to zanamivir and oseltamivir: a study performed on viruses circulating in France prior to the introduction of neuraminidase inhibitors in clinical practice. Antiviral Res. 2005, 68, 43-48.